|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
EBSCO_ocn957775670 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
160906s2016 nyu ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d EBLCP
|d SNK
|d DKU
|d AUW
|d IGB
|d D6H
|d VTS
|d AGLDB
|d G3B
|d S8J
|d S9I
|d STF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9781634856621
|q (electronic bk.)
|
| 020 |
|
|
|a 1634856627
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)957775670
|
| 050 |
|
4 |
|a RC48
|
| 060 |
1 |
4 |
|a WB 102
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Advances in medicine and biology.
|n Volume 103 /
|c Leon V. Berhardt, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c [2016]
|
| 264 |
|
4 |
|c ©2016
|
| 300 |
|
|
|a 1 online resource (xii, 236 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a ADVANCES IN MEDICINE AND BIOLOGY: VOLUME 103; ADVANCES IN MEDICINE AND BIOLOGY: VOLUME 103; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: THE EFFECT OF CARNITINE SUPPLEMENTATION ON HEPATIC ENCEPHALOPATHY (HE) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH); ABSTRACT; 1. INTRODUCTION; 2. HEPATIC ENCEPHALOPATHY (HE); 2.1. The Pathogenesis of HE; 2.2. The Diagnosis of HE; 2.3. The Treatment of HE; 2.3.1. Overview; 2.3.2. L-Carnitine Supplementation for HE; 3. NASH; 3.1. The Pathogenesis of NASH; 3.2. The Treatment of NASH; 3.3. L-Carnitine Supplementation for NASH
|
| 505 |
8 |
|
|a CONCLUSIONREFERENCES; BIOGRAPHICAL SKETCH; Chapter 2: THE ROLE OF ACYL/FREE CARNITINE RATIO ON UREMIC CARDIOMYOPATHY IN CHRONIC HEMODIALYSIS PATIENTS; ABSTRACT; INTRODUCTION; METHODS; Subjects; Echocardiographic Examination; Statistical Analysis; RESULTS; DISCUSSION; CONFLICT OF INTEREST; CONCLUSION; REFERENCES; BIOGRAPHICAL SKETCH; Chapter 3: FERMENTED MILK WITH LACTIC ACID BACTERIA ENRICHED OF ANGIOTENSIN-I CONVERTING ENZYME (ACE)-INHIBITORY PEPTIDES; ABSTRACT; 1. INTRODUCTION; 2. HYPERTENSION; 3. ANGIOTENSIN-I CONVERTING ENZYME (ACE); 4. ACE INHIBITORS; 5. FUNCTIONAL FOOD
|
| 505 |
8 |
|
|a 6. BIOACTIVE PEPTIDES IN FOOD PROTEINS7. PROTEOLYSIS OF MILK PROTEIN; 8. RELEASE OF ACE INHIBITORY PEPTIDESIN FERMENTED MILK; 9. ACE-INHIBITORY AND ANTIHYPERTENSIVEACTIVITY ASSAYS; CONCLUSION; REFERENCES; Chapter 4: BLACK TEA IN MILK AS A CARRIER AND SOURCE FOR POTENTIAL ANTIOXIDANT COMPOUNDS; ABSTRACT; 1. INTRODUCTION; 2. BLACK TEA; 3. COMPOSITION OF BLACK TEA; 4. POTENT SOURCE OF ANTIOXIDANT IN BLACK TEA; 5. THE ANTIOXIDANT POTENTIAL OFBLACK TEA WITH MILK; CONCLUSION; REFERENCES; Chapter 5: HOW TO DEAL WITH AORTIC VALVE STENOSIS IN PATIENTS AT INTERMEDIATEHIGH RISK IN THE MODERN ERA
|
| 505 |
8 |
|
|a ABSTRACT1. INTRODUCTION; 2. EPIDEMIOLOGY AND RISK CALCULATOR; 3. LITERATURE RESULTS; 4. INDICATIONS AND DEVICES FOR AVR; 5. DISCUSSION; REFERENCES; Chapter 6: DERMATOPHYTE INFECTIONS: CLINICAL SIGNS, DIAGNOSIS AND TOPICAL THERAPY; ABSTRACT; INTRODUCTION; EPIDEMIOLOGY; CLINICAL SIGNS; TINEA CAPITIS; TINEA CORPORIS; TINEA CRURIS; TINEA PEDIS; TINEA MANUUM; TINEA UNGUIUM; DIAGNOSIS; DIRECT EXAMINATION; CULTURE; HISTOPATHOLOGICAL EXAMINATION; MOLECULAR DETECTION; TOPICAL THERAPY; TOPICAL TREATMENT OF TINEA CAPITIS; TOPICAL TREATMENT OF TINEA INFECTION OF THE SKIN
|
| 505 |
8 |
|
|a TOPICAL TREATMENT OF TINEA UNGUIUMREFERENCES; Chapter 7: HUMAN CRYPTOSPORIDIOSIS: SPECIES, SUBTYPES, DIFFERENCES IN PATHOGENY AND CLINICAL MANIFESTATIONS, AND MATHEMATICAL METHODS FOR DNA SEQUENCE ANALYSIS; ABSTRACT; 1. INTRODUCTION; 2. PATHOGENY AND CLINICAL FEATURES INHUMAN CRYPTOSPORIDIOSIS; 2.1. Methodology; 2.1.1. Study Population and Enrollment; 2.1.2. Stool Samples Collection and Routine; Parasitological Investigations; 2 1.3. DNA Extraction, Genotyping and Subtyping; 2.1.4. Statistical Analysis; 2.2. Findings
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Internal medicine.
|
| 650 |
|
2 |
|a Internal Medicine
|
| 650 |
|
6 |
|a Médecine interne.
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a Internal medicine
|2 fast
|
| 700 |
1 |
|
|a Berhardt, Leon V.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Advances in medicine and biology. Volume 103.
|d New York : Nova Biomedical, [2016]
|z 9781634856522
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1345798
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4691189
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1345798
|
| 994 |
|
|
|a 92
|b IZTAP
|
